We serve Chemical Name:3-Isopropoxyazetidine hydrochloride CAS:871657-49-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Isopropoxyazetidine hydrochloride
CAS.NO:871657-49-7
Synonyms:QC-7424;3-Isopropoxyazetidine hydrochloride;3-(propan-2-yloxy)azetidine hydrochloride
Molecular Formula:C6H14ClNO
Molecular Weight:151.63400
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:21.26000
Exact Mass:151.07600
LogP:1.51400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like QC-7424 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(propan-2-yloxy)azetidine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Isopropoxyazetidine hydrochloride Use and application,3-Isopropoxyazetidine hydrochloride technical grade,usp/ep/jp grade.
Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. 3-Isopropoxyazetidine hydrochloride manufacturer ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� 3-Isopropoxyazetidine hydrochloride supplier The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. 3-Isopropoxyazetidine hydrochloride vendor The fine chemical industry includes fine chemicals and special chemicals. Fine chemical products have the characteristics of a small amount of production, relatively specific application fields, and long and complex industrial chains. They are mainly used in medicine, pesticides, dyes, liquid crystals and other fields. 3-Isopropoxyazetidine hydrochloride factory The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.
